- As many as 44 million workers in the European Union (EU) are affected by workplace-related musculoskeletal disorders, representing a total annual cost to industry of more than $300 billion
- Exoskeleton use could alleviate 10-40% of muscle peak loads for passive exoskeletons and up to 80% for active
- The EXSKALLERATE project will enhance the adoption of exoskeletons by the manufacturing and building industry. This will reduce and occupational health and therefore SME competitiveness in the North Sea Region and creates a worldwide leading exoskeleton ecosystem
Barcelona, April 17, 2020. A new initiative aims to accelerate the adoption of exoskeletons into construction and industrial manufacturing SMEs across Europe’s North Sea Region. EXSKALLERATE, which launched in January, will over the next three years enhance SME competitiveness and occupational health by transforming the North Sea Region into a leading exoskeleton ecosystem.
As many as 44 million workers in the European Union (EU) are affected by workplace-related musculoskeletal disorders, representing a total annual cost to industry of more than $300 billion. Exoskeletons have the capacity to decrease the number of musculoskeletal injuries and increase quality of life at work, thereby reducing costs for a company in the long run.
Manufacturing and construction workers, in particular, undertake physically strenuous activities which increase their risk of health problems, disability and sick leave. This leads to lower job attractiveness and job candidate scarcity, resulting in unfilled job openings that slow growth and competitiveness. This is particularly true for many SMEs in the North Sea Region, who are unaware of available solutions via exoskeleton adoption as solution developers tend to target large corporates.
EXSKALLERATE aims to tackle these issues by focusing on boosting SME adoption of exoskeletons in the construction and industrial manufacturing industries, where heavy physical work leads to severe health issues. According to research conducted by the EXSKALLERATE partners, exoskeleton use could alleviate 10-40% of muscle peak loads for passive exoskeletons, and up to 80% for active.
The consortium of business support organisations, clusters, and research institutes from six European countries, will co-design field labs according to the main SME challenges identified, where next-generation exoskeletons integrate improvements. The partners will also host several informative workshops for SMEs where exoskeleton experts will present tools to support SME decision making in exoskeleton adoption, a key challenge limiting current adoption.
EXSKALLERATE, co-funded by the Interreg North Sea Region Programme 2014 - 2020, welcomes construction and industrial manufacturing SMEs to get involved and reap the benefits of exoskeletons.